The association of circulating 25-hydroxyvitamin D concentration with peripheral arterial disease: A meta-analysis of observational studies

Atherosclerosis

Volumn 243, Issue 2, 2015, Pages 645-651

  Nsengiyumva, Vianne ^a   Fernando, Malindu E ^a   Moxon, Joseph V ^a   Krishna, Smriti M ^a   Pinchbeck, Jenna ^a   Omer, Safraz M ^a   Morris, Dylan R ^a   Jones, Rhondda E ^a   Moran, Corey S ^a   Seto, Sai W ^b   Golledge, Jonathan ^a,c  

^a JAMES COOK UNIVERSITY   (Australia)

^b WESTERN SYDNEY UNIVERSITY   (Australia)

^c TOWNSVILLE HOSPITAL   (Australia)

Author keywords

25 Hydroxyvitamin D; Atherosclerosis; Atherothrombosis; Meta analysis; Peripheral arterial disease; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; VITAMIN D;

CRITICAL LIMB ISCHEMIA; HUMAN; INTERMITTENT CLAUDICATION; META ANALYSIS; OBSERVATIONAL STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CRITICAL ILLNESS; DOWN REGULATION; ISCHEMIA; PERIPHERAL ARTERIAL DISEASE; PROGNOSIS;

BIOMARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CRITICAL ILLNESS; DOWN-REGULATION; HUMANS; ISCHEMIA; OBSERVATIONAL STUDIES AS TOPIC; PERIPHERAL ARTERIAL DISEASE; PROGNOSIS; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84946565298     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.10.011     Document Type: Review

References (41)

1. Golledge J. Lower-limb arterial disease. Lancet 1997, 350(9089):1459-1465.
2. McDermott M.M., Liu K., Ferrucci L., Tian L., Guralnik J., Kopp P., Van Horn L., et al. Vitamin D status, functional decline, and mortality in peripheral artery disease. Vasc. Med. 2014, 19(1):18-26.
3. Fowkes F.G., Rudan D., Rudan I., Aboyans V., Denenberg J.O., McDermott M.M., et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013, 382(9901):1329-1340.
4. Gaddipati V.C., Bailey B.A., Kuriacose R., Copeland R.J., Manning T., Peiris A.N. The relationship of vitamin D status to cardiovascular risk factors and amputation risk in veterans with peripheral arterial disease. J. Am. Med. Dir. Assoc. 2011, 12(1):58-61.
5. Brostow D.P., Hirsch A.T., Collins T.C., Kurzer M.S. The role of nutrition and body composition in peripheral arterial disease. Nat. Rev. Cardiol. 2012, 9(11):634-643.
6. Kassi E., Adamopoulos C., Basdra E.K., Papavassiliou A.G. Role of vitamin D in atherosclerosis. Circulation 2013, 128(23):2517-2531.
7. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357(3):266-281.
8. Carvalho L.S., Sposito A.C. Vitamin D for the prevention of cardiovascular disease: are we ready for that?. Atherosclerosis 2015, 241(2):729-740.
9. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96(7):1911-1930.
10. Kim D.H., Sabour S., Sagar U.N., Adams S., Whellan D.J. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am. J. Cardiol. 2008, 102(11):1540-1544.
11. Melamed M.L., Muntner P., Michos E.D., Uribarri J., Weber C., Sharma J., et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease - results from NHANES 2001 to 2004. Arterioscler. Thromb. Vasc. Biol. 2008, 28(6):1179-1185.
12. van de Luijtgaarden K.M., VoÛte M.T., Hoeks S.E., Bakker E.J., Chonchol M., Stolker R.J., et al. Vitamin D deficiency may be an independent risk factor for arterial disease. Eur. J. Vasc. Endovasc. Surg. 2012, 44(3):301-306.
13. Reis J.P., Michos E.D., von Muhlen D., Miller E.R. Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am. J. Clin. Nutr. 2008, 88(6):1469-1477.
14. Liew J.Y., Sasha S.R., Ngu P.J., Warren J.L., Wark J., Dart A.M., et al. Circulating vitamin D levels are associated with the presence and severity of coronary artery disease but not peripheral arterial disease in patients undergoing coronary angiography. Nutr. Metab. Cardiovasc Dis. 2015, 25(3):274-279.
15. McDermott M.M., Liu K., Ferrucci L., Tian L., Guralnik J., Kopp P., et al. Vitamin D status and functional performance in peripheral artery disease. Vasc. Med. 2012, 17(5):294-302.
16. Veronese N., Rui M., Bolzetta F., Toffanello E.D., Coin A., Zambon S., et al. Serum 25-hydroxyvitamin d and the incidence of peripheral artery disease in the elderly: the PRO. VA study. J. Atheroscler. Thromb. 2015, 22(7):726-734.
17. Moher D., Liberati A., Tetzlaff J., Altman D.G. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int. J. Surg. 2010, 8(5):336-341.
18. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 2000, 283(15):2008-2012.
19. Moher D., Shamseer L., Clarke M., Ghersi D., Liberati A., Petticrew M., et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst. Rev. 2015, 4(1):1-9.
20. Sanderson S., Tatt I.D., Higgins J.P. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int. J. Epidemiol. 2007, 36(3):666-676.
21. Glynn L. A critical appraisal tool for library and information research. Libr. Hi Tech. 2006, 24(3):387-399.
22. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 2010, 25(9):603-605.
23. Fahrleitner A., Dobnig H., Obernosterer A., Pilger E., Leb G., Weber K., et al. Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease. J. Gen. Intern Med. 2002, 17(9):663-669.
24. Fahrleitner-Pammer A., Obernosterer A., Pilger E., Dobnig H., Dimai H.P., Leb G., et al. Hypovitaminosis D, impaired bone turnover and low bone mass are common in patients with peripheral arterial disease. Osteoporos. Int. 2005, 16(3):319-324.
25. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011, Available from:, Accessed June 2015. http://www.cochrane-handbook.org, J.P. Higgins, S. Green (Eds.).
26. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327(7414). 557-5560.
27. Sterne J.A., Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J. Clin. Epidemiol. 2001, 54(10):1046-1055.
28. Moxon J.V., Liu D., Wong G., Weir J.M., Behl-Gilhotra R., Bradshaw B., et al. Comparison of the serum lipidome in patients with abdominal aortic aneurysm and peripheral artery disease. Circ. Cardiovasc. Genet. 2014, 7(1):71-79.
29. Wong Y.Y., Flicker L., Yeap B.B., McCaul K.A., Hankey G.J., Norman P.E. Is hypovitaminosis D associated with abdominal aortic aneurysm, and is there a dose-response relationship?. Eur. J. Vasc. Endovasc. Surg. 2013, 45(6):657-664.
30. Zagura M., Serg M., Kampus P., Zilmer M., Eha J., Unt E., et al. Aortic stiffness and vitamin D are independent markers of aortic calcification in patients with peripheral arterial disease and in healthy subjects. Eur. J. Vasc. Endovasc. Surg. 2011, 42(5):689-695.
31. Smith G.D., Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 2014, 23(R1):R89-R98.
32. Ye Z., Sharp S.J., Burgess S., Scott R.A., Imamura F., InterAct Consortium, et al. Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol. 2015, 3(1):35-42.
33. Wang T.J., Zhang F., Richards J.B., Kestenbaum B., van Meurs J.B., Berry D., et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010, 376(9736):180-188.
34. Norman P.E., Powell J.T. Vitamin d and cardiovascular disease. Circ. Res. 2014, 114(2):379-393.
35. Ohsawa M., Koyama T., Yamamoto K., Hirosawa S., Kamei S., Kamiyama R. 1α, 25-dihydroxyvitamin D3 and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation 2000, 102(23):2867-2872.
36. Artaza J.N., Mehrotra R., Norris K.C. Vitamin D and the cardiovascular system. Clin. J. Am. Soc. Nephrol. 2009, 4(9):1515-1522.
37. Nakagawa K., Sasaki Y., Kato S., Kubodera N., Okano T. 22-Oxa-1α, 25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer. Carcinogenesis 2005, 26(6):1044-1054.
38. YC1 Li, Qiao G., Uskokovic M., Xiang W., Zheng W., Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J. Steroid Biochem. Mol. Biol. 2004, 89(5):387-392.
39. Brown J., de Boer I.H., Robinson-Cohen C., Siscovick D.S., Kestenbaum B., Allison M., et al. Aldosterone, parathyroid hormone, and the use of renin-angiotensin-aldosterone system inhibitors: the multi-ethnic study of atherosclerosis. J. Clin. Endocrinol. Metab. 2015, 100(2):490-499.
40. Verdoia M., Schaffer A., Barbieri L., Di Giovine G., Marino P., Suryapranata H., et al. Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease. Nutr. Metab. Cardiovasc Dis. 2015, 25(5):464-470.
41. Carter G.D. Accuracy of 25-hydroxyvitamin D assays: confronting the issues. Curr. Drug Targets 2011, 12(1):19-28.